SCHEMBL22014737

SCHEMBL22014737

CCc1c2c(cc(C(C)C)c1CC(C)=O)COC2

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21962256 0.89 HSP90AB1 (0.33) HSP90AB1
SCHEMBL22014999 0.85
SCHEMBL22014721 0.85
SCHEMBL25067134 0.76
SCHEMBL22014997 0.76
SCHEMBL21962221 0.74 KDM4E (0.32)
SCHEMBL22015607 0.73 HSP90AA1 (0.33) HSP90AB1
SCHEMBL23319827 0.73
SCHEMBL21962898 0.71 PLA2G10 (0.30)
SCHEMBL22015606 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102574-A1 THE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed